No Data
A Quick Look at Today's Ratings for TG Therapeutics(TGTX.US), With a Forecast Between $38 to $55
TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TG Therapeutics Boosts Revenue Outlook Amidst Growth
B. Riley Remains a Buyer of TG Therapeutics on Weakness Following Q3 Results
TG Therapeutics Price Target Raised to $55 From $49 at H.C. Wainwright
TG Therapeutics: Promising Growth Trajectory and Blockbuster Potential Justify Buy Rating